Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Palmm is a medical technology company developing a wearable, at-home treatment for palmar hyperhidrosis, a condition characterized by excessive hand sweating. The company's core product is a thin, flexible electronic device that utilizes iontophoresis technology to reduce sweat production by delivering a mild electrical current to the skin. Designed for convenience, the wearable glove allows users to remain mobile and perform daily tasks during treatment, addressing the limitations of traditional, bulky iontophoresis machines. Palmm aims to provide a more accessible and user-friendly alternative to clinical procedures or prescription topicals. The company is currently focused on clinical validation and regulatory pathways to bring its solution to the millions of individuals affected by hyperhidrosis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Palmm.